Mitsubishi Tanabe Pharma Corporation

Type: Company
Name: Mitsubishi Tanabe Pharma Corporation
First reported Apr 17 2014 - Updated Apr 18 2014 - 1 reports

Cohen’s Point72 Asset Management buys a stake in Cytokinetics

Steven Cohen's Point72 Asset Management updates its portfolio (Part 2 of 5)( Continued from Part 1 )Point72 Asset Management and CytokineticsSteven Cohen’s Point72 Asset Management, which was earlier known as SAC Capital, initiated a new position in Cytokinetics ... [Published Yahoo! Finance - Apr 17 2014]
First reported Apr 15 2014 - Updated Apr 16 2014 - 2 reports

Rheumatoid Arthritis - Pipeline Review, H1 2014: New Research Report Available at Fast Market Research

recommends "Rheumatoid " from Global Markets Direct, now availableBoston, MA -- (SBWIRE) -- 04/16/2014 -- Global Markets Direct's, 'Rheumatoid ', provides an overview of the Rheumatoid Arthritis's therapeutic pipeline.This report provides comprehensive ... [Published Digital Journal - Apr 16 2014]
First reported Apr 12 2014 - Updated Apr 12 2014 - 1 reports

Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018

Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database.Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals ... [Published MySanAntonio - Apr 12 2014]
Entities: Biologics, Biology, Market
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Global amyotrophic lateral sclerosis drugs market forecast to expand by 5.4% CAGR during 2013 to 2018

- Global Amyotrophic Lateral Sclerosis Market 2014-2018 - a new market research report on companiesandmarkets.comThe Global Amyotrophic Lateral Sclerosis Drugs Market is forecast to grow at a CAGR of 5.39 percent over the period 2013-2018. One of the ... [Published PR inside - Apr 11 2014]
First reported Apr 09 2014 - Updated Apr 10 2014 - 1 reports

Global Diabetic Nephropathy Market 2014-2018 with Merck & Co, Mitsubishi Tanabe Pharma, Novartis AG & Sanofi S.A. Dominating

Research and Markets (http://www.researchandmarkets.com/research/73nzx7/global_diabetic) has announced the addition of the "" report to their offering. The Global Diabetic Nephropathy market will grow at a CAGR of 5% over the period 2013-2018. One of ... [Published Individual.com - Apr 09 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

CMIC Holdings acquires company from Mitsubishi Tanabe Pharma

8:00am BSTCMIC Holdings Co Ltd:Completed acquisition of 2,000 shares (100 pct voting power) in a Japan-based pharmaceutical company to take over Ashikaga plant from Mitsubishi Tanabe Pharma Corp, for 3,318 mln yen on April 1. ... [Published Reuters UK - Apr 01 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

Surveyed U.S. Psychiatrists Would Prescribe EnVivo Pharmaceuticals' Encenicline to 25 Percent of their Patients with Cognitive Impairment Associated with Schizophrenia

BURLINGTON, Mass., March 31, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. psychiatrists would prescribe EnVivo Pharmaceuticals/Bayer HealthCare/Mitsubishi Tanabe Pharma's encenicline to 25 percent of their patients with cognitive ... [Published PR Newswire: General Business - Mar 31 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Global Generic Drugs Market 2014-2018: Branded Drugs with Sales of Up to US$135 Billion to Go Off-Patent by 2015

Research and Markets (http://www.researchandmarkets.com/research/6q8j7g/global_generic) has announced the addition of the "Global Generic Drugs Market 2014-2018" report to their offering. The analysts forecast the Global Generic Drugs market to grow at ... [Published Individual.com - Mar 24 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

Global Diabetic Nephropathy Market 2014-2018

ReportsnReports.com adds report to its store. Diabetic nephropathy is a disease of thekidney glomerulus, which is caused by high blood sugar. When diabetesdamages kidneys, which contain millions of tiny blood vessel clusters(glomeruli) that filter waste ... [Published PitchEngine - Mar 19 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 1 reports

Generic Drugs Market 2014 - 2018 Global Report

Dallas, TX -- ( SBWIRE ) -- 03/14/2014 -- Mergers and acquisitions has become the core growth strategy among many healthcare vendors; they help vendors grow rapidly and expand their businesses. The Global Generic Drugs market has witnessed a number of ... [Published SBWire - Mar 14 2014]
Entities: Drugs, Actavis, Market
First reported Mar 13 2014 - Updated Mar 13 2014 - 1 reports

Global Generic Drugs Market 2014-2018

Reportstack has announced a new market research publication on   which forecasts that the market is expected to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing ... [Published PitchEngine - Mar 13 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Find Your Next Asia Partnership in Tokyo at BIO Asia

On April 8-9, 2014, the  BIO Asia International Conference  will enter its eleventh year. This year, bioparma industry leaders will convene at the Grand Hyatt in Tokyo, Japan to make the cross border deals that will advance collaboration between Asia ... [Published I Am Biotech - Mar 12 2014]

Quotes

Boston, MA -- (SBWIRE) -- 04/16/2014 -- Global Markets Direct's, "Rheumatoid ', provides an overview of the Rheumatoid Arthritis's therapeutic pipeline."
Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database
Title: "Use of Avanafil and Successful Intercourse Within Approximately 15 Minutes of Dosing in Men With Mild to Severe Erectile Dysfunction"
...two exciting product launches and the significant progress we've made transforming Auxilium," said Adrian Adams, CEO and President of Auxilium. "We have grown from a two-product company to a leading men's healthcare company with a broadened portfolio of 12 approved products.  Across this expanded portfolio, we now have five products that we believe are growth assets, including two new products in men's healthcare that were recently launched in the beginning of 2014. We launched an additional indication for XIAFLEX - the first and only proven safe and effective FDA-approved treatment for Peyronie's disease in men with a curvature deformity of ≥30° at the start of therapy. We also launched STENDRA, a next generation, differentiated PDE5 inhibitor and the first new drug entry into the $3 billion erectile dysfunction market in nearly a decade. This is an exciting time for Auxilium and we believe that we are well positioned to deliver growth and to build long-term shareholder value."

More Content

All (27) | News (21) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (2) | Press Releases (1)
sort by: Date | Relevance
Cohen’s Point72 Asset Management buys a stake i... [Published Yahoo! Finance - Apr 17 2014]
Rheumatoid Arthritis - Pipeline Review, H1 2014... [Published Digital Journal - Apr 16 2014]
New Market Research Report: Alzheimer's Disease... [Published SBWire - Apr 15 2014]
Biosimilar And Follow-On Biologics Market - Glo... [Published MySanAntonio - Apr 12 2014]
VIVUS : Avanafil Clinical Data to Be Presented ... [Published 4 Traders - Apr 11 2014]
Global amyotrophic lateral sclerosis drugs mark... [Published PR inside - Apr 11 2014]
Global Diabetic Nephropathy Market 2014-2018 wi... [Published Individual.com - Apr 09 2014]
CMIC Holdings acquires company from Mitsubishi ... [Published Reuters UK - Apr 01 2014]
Surveyed U.S. Psychiatrists Would Prescribe EnV... [Published PR Newswire: General Business - Mar 31 2014]
Global Generic Drugs Market 2014-2018: Branded ... [Published Individual.com - Mar 24 2014]
Global Diabetic Nephropathy Market 2014-2018 [Published PitchEngine - Mar 19 2014]
SADIF Analytics releases new summary due dilige... [Published PR inside - Mar 18 2014]
Auxilium Pharmaceuticals : To Ring the NASDAQ S... [Published 4 Traders - Mar 17 2014]
Generic Drugs Market 2014 - 2018 Global Report [Published SBWire - Mar 14 2014]
Now Available: Tanabe Research Laboratories U.S... [Published Live-PR.com - Mar 14 2014]
Global Generic Drugs Market 2014-2018 [Published PitchEngine - Mar 13 2014]
Find Your Next Asia Partnership in Tokyo at BIO... [Published I Am Biotech - Mar 12 2014]
Global Over-the-counter (OTC) Pharmaceutical Ma... [Published GlobeNewswire - Nov 21 2013]
Auxilium to market Vivus' erectile dysfunction ... [Published Pharmaceutical Technology - Oct 14 2013]
Auxilium Pharma to market VIVUS's ED drug, Sten... [Published PharmaBiz - Oct 14 2013]
Real-world evidence showed superiority of Novar... [Published PharmaBiz - Oct 03 2013]
Medicago Announces 2013 Second Quarter Financia... [Published PR Newswire - Aug 09 2013]
VIVUS Reports Second Quarter and First Six Mont... [Published GlobeNewswire - Aug 06 2013]
IVUS inks agreement with Sanofi to manufacture ... [Published PharmaBiz - Aug 03 2013]
BioInvent delårsrapport 1 januari – 30 juni 2013 [Published GlobeNewswire - Jul 25 2013]
Fact Sheet for Mitsubishi Chemical Holdings Corp [Published Silobreaker - Feb 05 2010]
Fact Sheet for Mitsubishi Chemical Holdings Cor... [Published Able2Act - Dec 28 2007]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Surveyed U.S. Psychiatrists Would Prescribe EnV... [Published PR Newswire: General Business - Mar 31 2014]
BURLINGTON, Mass., March 31, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. psychiatrists would prescribe EnVivo Pharmaceuticals/Bayer HealthCare/Mitsubishi Tanabe Pharma's encenicline to 25 percent of their patients with cognitive ...
Find Your Next Asia Partnership in Tokyo at BIO... [Published I Am Biotech - Mar 12 2014]
On April 8-9, 2014, the  BIO Asia International Conference  will enter its eleventh year. This year, bioparma industry leaders will convene at the Grand Hyatt in Tokyo, Japan to make the cross border deals that will advance collaboration between Asia ...
1

Press Releases

sort by: Date | Relevance
Medicago Announces 2013 Second Quarter Financia... [Published PR Newswire - Aug 09 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.